Antioxidative properties of vitamin E as a new approach to its applications in therapy;Włásciwości antyoksydacyjne witaminy E podstawa̧ jej nowych zastosowań w terapii

Polski Merkuriusz Lekarski

Volumn 20, Issue 119, 2006, Pages 609-614

  Rutkowski, Maciej ^a   Grzegorczyk, Krzysztof ^a   Chojnacki, Jan ^a   Kȩdziora, Józef ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidative action of vitamin E; Neoplasms and cardiovascular diseases prevention role of vitamin E as an antioxidant; Undesirable effects

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; CANCER; CARDIOVASCULAR DISEASE; DRUG DOSE; DRUG EFFECT; HUMAN; OXIDATIVE STRESS; REVIEW; UNSPECIFIED SIDE EFFECT; VITAMIN DEFICIENCY; NEOPLASM;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; OXIDATIVE STRESS; VITAMIN E;

EID: 33744486083     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Basile G., Gangemi S., Lo Balbo C. i wsp.: Correlation between serum retinol and alpha-tocopherol levels In centenarians. J. Nutr. Sci. Vitaminol., Tokyo. 2003, 49, 287.
2. Berg B.M., Godbout J.P., Kelley K.W., Johnson R.W.: Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav. Immun., 2004, 18, 149.
3. Brown B.G., Zhao X.Q., Chait A. i wsp.: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med., 2001, 345, 1583.
4. Burkitt M.J.: A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation - roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplazmin. Arch. Biochem. Biophys., 2001, 394, 117.
5. Centanni S., Santus P., Di Marco F. i wsp.: The potential role of tocopherol in asthma and allergies: modification of the leukotriene pathway. BioDrugs, 2001, 15, 81.
6. Comporti M.: Lipid peroxidation and biogenic aldehydes - from identification of 4-hydroxynonenal to further achievements in biopathology. Free Radic. Res., 1998, 28, 623.
7. Dorgan J.F., Sowell A., Swanson C.A. i wsp.: Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk - results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control, 1998, 9, 89.
8. Eichholzer M., Stahelin N.B., Gey K.F i wsp.: Prediction of male cancer mortality by plasma levels of interacting vitamins - 17-year follow-up of the prospective Basel study. Int. J. Cancer, 1996, 66, 145.
9. Gebicki J.M.: Protein hydroperoxides as new reactive oxygen species. Redox Report, 1997, 3, 99.
10. GISSI (Gruppo Italiano per lo Studio delle Streptochinasi nell'Infarto Miocardico) - Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction - results of the GISSI-Prevenzione Trial. Lancet, 1999, 354, 447.
11. Halliwell B., Zhao K., Whiteman M.: Nitric oxide and peroxynitnte. The ugly, the uglier and the not so good - a personal view of recent controversies. Free Radic. Res., 1999, 31, 651.
12. Halliwell B.: Establishing the significance and optimal intake of dietary antioxidants. Nutr. Rev., 1999, 57, 104.
13. Hamilton I.M., Gilmore W.S., Benzie I.F i wsp.: Interactions between vitamins C and E in human subjects. Br. J. Nutr., 2000, 84, 261.
14. Hofstad B., Almendingen K., Vatn M. i wsp.: Growth and recurrence of colorectal polyps - a double-blind 3-year intervention with calcium and antioxidants. Digestion, 1998, 59, 148.
15. HOPE (Heart Outcomes Prevention Evaluation) Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med., 2000, 342, 154.
16. Islam K.N., Devaraj S., Jialal I.: Alpha-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation, 1998, 98, 2255.
17. Itabe H., Takano T.: Oxidized low density lipoprotein - the occurrence and metabolism in circulation and in foam cells. J. Atheroscler. Thromb., 2000, 7, 123.
18. Jacobs E.J., Connell C.J., Patel A.V. i wsp.: Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society Cohort Study. Cancer Epidemiol. Biomark. Prev., 2001, 10, 17.
19. Jiang Q., Elson-Schwab I., Courtemanche C. i wsp.: Gamma-Tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci., USA. 2000, 97, 11494.
20. Kamal-Aldin A., Appelquist L.A.: The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids, 1996, 31, 671.
21. Kartal-Ozer N., Negis Y., Aytan N.: Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclerosis - role of vitamin E. Biofactors, 2003, 19, 63.
22. Kehrer J.P.: The Haber-Weiss reaction and mechanisms of toxicity. Toxicology, 2000, 14, 43.
23. Leppala J.M., Virtamo J., Fogelholm R. i wsp.: Vitamin E and beta-carotene supplementation in high risk for stroke - a subgroup analysis of the Alpha-Tocopherol Beta-Carotene (ATBC) Cancer Prevention Study Group. Arch. Neurol., 2000, 57, 1503.
24. Liu M., Wallin R., Wallmon A. i wsp.: Mixed tocopherols have a stronger inhibitory effect on lipid peroxidation than alpha-tocopherol alone. J. Cardiovasc. Pharmacol., 2002, 39, 714.
25. Malila N., Virtamo J., Virtanen M. i wsp.: Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers. ATBC (Alpha-Tocopherol, Beta-Carotene) Cancer Prevention Study Group. Eur. J. Clin. Nutr., 2002, 56, 615.
26. Niki E., Kawakami A., Saito M. i wsp.: Effect of phytyl side chain of vitamin E on its antioxidant activity. J. Biol. Chem., 1985, 260, 2191.
27. Palozza P., Krinsky N.: Beta-carotene and alpha-tocopherol are synergistic antioxidants. Arch. Biochem. Biophys., 1992, 297, 184.
28. Pratico D., Tangirala R.K., Rader D.J. i wsp.: Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat. Med., 1998, 4, 1189.
29. Rapola J.M., Virtamo J., Ripatti S. i wsp.: Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet, 1997, 349, 1715.
30. Rota S., McWilliam N.A., Baglin T.P. i wsp.: Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation - modulation by oxidation and vitamin E. Blood, 1998, 91, 508.
31. Stephens N.G., Parsons A., Schofield P.M. i wsp.: Randomised controlled trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant Study (CHAOS). Lancet, 1996, 347, 781.
32. Stone W.L., Papas A.M.: Tocopherols and the etiology of colon cancer. J. Natl. Canc. Inst., 1997, 89, 1006.
33. Taylor P.R., Qiao Y.L., Abnet C.C. i wsp.: Prospective study of serum vitamin E levels and esophageal and gastric cancers. J. Natl. Cancer Inst., 2003, 95, 1414.
34. Vilar R.E., Ghael D., Li M. i wsp.: Nitric oxide degradation of heparin and heparan sulphate. Biochem. J., 1997, 324, 473.
35. Virtamo J., Edwards B.K., Virtanen M. i wsp.: Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer - incidence and mortality in a controlled trial (Finland). ATBC (Alpha-Tocopherol, Beta-Carotene) Cancer Prevention Study Group, 2000, 11, 933.
36. Wardman P., Candeias L.P.: Fenton chemistry - an introduction. Radiat. Res., 1996, 145, 523.
37. White B.C., Sullivan J.M., De Gracia D.J. i wsp.: Brain ischemia and reperfusion - molecular mechanisms of neuronal injury. J. Neurol. Sci., 2000, 179, 1.
38. Williams G.M., Jeffrey A.M.: Oxidative DNA damage - endogenous and chemically induced. Regul. Toxicol. Pharmacol., 2000, 32, 283.
39. Yong L.C., Brown C.C., Schatzkin A. i wsp.: Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I Epidemiologic Follow-up Study. Am. J. Epidemiol., 1997, 146, 231.
40. Young I.S., Woodside J.V.: Antioxidants in health and disease. J. Clin. Pathol., 2001, 54, 176.